alpha 1-proteinase inhibitor, human 1 MG Injection

RxNorm concept 1661208, clinical drug (scd).

RxCUI: 1661208
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1661208 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

alpha 1-antitrypsin 535

Related concepts

alpha 1-proteinase inhibitor, human 1 MG (SCDC, consists of)
Injection (DF, has dose form)
alpha 1-proteinase inhibitor, human 1 MG Injection [Zemaira] (SBD, has tradename)
alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] (SBD, has tradename)
alpha 1-proteinase inhibitor, human 1 MG Injection [Aralast] (SBD, has tradename)
alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin] (SBD, has tradename)

Linked data

NDCs

57516010201
57516011101
57516011401

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1661208 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1661208 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1661208. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.